Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19.

MLA

Sarah E Holton, et al. “Mediators of Monocyte Chemotaxis and Matrix Remodeling Are Associated with Mortality and Pulmonary Fibroproliferation in Patients with Severe COVID-19.” PLoS ONE, vol. 19, no. 8, Jan. 2024, p. e0285638. EBSCOhost, https://doi.org/10.1371/journal.pone.0285638&type=printable.

APA

Sarah E Holton, Mallorie Mitchem, Hamid Chalian, Sudhakar Pipavath, Eric D Morrell, Pavan K Bhatraju, Jessica A Hamerman, Cate Speake, Uma Malhotra, Mark M Wurfel, Steven E Ziegler, & Carmen Mikacenic. (2024). Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19. PLoS ONE, 19(8), e0285638. https://doi.org/10.1371/journal.pone.0285638&type=printable

Chicago

Sarah E Holton, Mallorie Mitchem, Hamid Chalian, Sudhakar Pipavath, Eric D Morrell, Pavan K Bhatraju, Jessica A Hamerman, et al. 2024. “Mediators of Monocyte Chemotaxis and Matrix Remodeling Are Associated with Mortality and Pulmonary Fibroproliferation in Patients with Severe COVID-19.” PLoS ONE 19 (8): e0285638. doi:10.1371/journal.pone.0285638&type=printable.